ZNTL · Zentalis Pharmaceuticals Inc. Common Stock
View on chartInsiders & Stakes
| WALTERS GROUP 10% Owner | ▲ Buy | Open Market | 17,844,973 Shares held | 8/14/2026 | View profile |
| Matrix Capital Management Company, LP 10% Owner | ▼ Sell | Open Market | 6,459,973 Shares held | 12/15/2025 | View profile |
| SUN ANTHONY Y President & CEO | ▼ Sell | Open Market | 1,175,589 Shares held | 4/5/2022 | View profile |
| Andrea Paul General Counsel | ▼ Sell | Open Market | 1,070,784 Shares held | 2/3/2025 | View profile |
| Bunker Kevin D. Chief Operating Officer | ▼ Sell | Gift | 834,931 Shares held | 12/20/2023 | View profile |
| Cam Gallagher Director | ▼ Sell | Open Market | 633,680 Shares held | 5/31/2024 | View profile |
| Mark Lackner Chief Scientific Officer | ▼ Sell | Open Market | 512,856 Shares held | 2/3/2025 | View profile |
| Blackwell Kimberly Director | ▼ Sell | Tax Withholding | 484,145 Shares held | 2/1/2024 | View profile |
| Epperly Melissa B, Director | ▼ Sell | Open Market | 451,449 Shares held | 2/12/2024 | View profile |
| Scott Dunseth Myers Director | ▲ Buy | Grant | 395,895 Shares held | 6/16/2026 | View profile |
| Diana Hausman Director | ▼ Sell | Open Market | 373,876 Shares held | 5/9/2024 | View profile |
| David Michael Johnson Director | ▲ Buy | Grant | 307,521 Shares held | 6/16/2026 | View profile |
| Jan Skvarka Director | ▲ Buy | Grant | 264,254 Shares held | 6/16/2026 | View profile |
| Luke Nathaniel Walker Director | ▲ Buy | Grant | 201,384 Shares held | 6/16/2026 | View profile |
| Enoch Kariuki Director | ▲ Buy | Grant | 194,465 Shares held | 6/16/2026 | View profile |
| Vincent Vultaggio Principal Accounting Officer | ▼ Sell | Open Market | 146,506 Shares held | 2/10/2026 | View profile |
| Shannon Campbell Director | ▲ Buy | Grant | 114,200 Shares held | 5/26/2026 | View profile |
| Brownstein Carrie Chief Medical Officer | ▼ Sell | Open Market | 105,685 Shares held | 10/4/2023 | View profile |
| Julia Marie Eastland CEO & President | ▼ Sell | Open Market | 79,133 Shares held | 2/9/2026 | View profile |
| Roth Iris Chief Operating Officer | ▲ Buy | Grant | 52,500 Shares held | 3/1/2023 | View profile |
| Ingmar Bruns Chief Medical Officer | ▲ Buy | Grant | 43,059 Shares held | 9/30/2026 | View profile |
| Pinto Alexis Chief Legal Officer | ▼ Sell | Open Market | 22,240 Shares held | 2/14/2022 | View profile |
| Voliotis Dimitris SVP, Clinical Development | ▼ Sell | Open Market | 15,978 Shares held | 2/14/2022 | View profile |
Transaction History
| Ingmar Bruns | ▲ Buy | Grant | 9,727 | $21K | 9/30/2026 |
| WALTERS GROUP | ▲ Buy | Open Market | 4,335,000 | $15.2M | 8/14/2026 |
| Jan Skvarka | ▲ Buy | Grant | 57,100 | $0 | 6/16/2026 |
| David Michael Johnson | ▲ Buy | Grant | 57,100 | $0 | 6/16/2026 |
| Luke Nathaniel Walker | ▲ Buy | Grant | 57,100 | $0 | 6/16/2026 |
| Enoch Kariuki | ▲ Buy | Grant | 57,100 | $0 | 6/16/2026 |
| Scott Dunseth Myers | ▲ Buy | Grant | 57,100 | $0 | 6/16/2026 |
| Shannon Campbell | ▲ Buy | Grant | 114,200 | $0 | 5/26/2026 |
| Vincent Vultaggio | ▼ Sell | Open Market | 6,894 | $17K | 2/10/2026 |
| Ingmar Bruns | ▼ Sell | Open Market | 335 | $802 | 2/9/2026 |
| Vincent Vultaggio | ▼ Sell | Open Market | 3,379 | $8K | 2/9/2026 |
| Julia Marie Eastland | ▼ Sell | Open Market | 889 | $2K | 2/9/2026 |
| Ingmar Bruns | ▼ Sell | Open Market | 2,962 | $7K | 2/6/2026 |
| Vincent Vultaggio | ▼ Sell | Open Market | 29,951 | $73K | 2/6/2026 |
| Julia Marie Eastland | ▼ Sell | Open Market | 7,866 | $19K | 2/6/2026 |
| Vincent Vultaggio | ▼ Sell | Open Market | 556 | $1K | 2/3/2026 |
| Vincent Vultaggio | ▼ Sell | Open Market | 2,540 | $6K | 2/2/2026 |
| WALTERS GROUP | ▲ Buy | Open Market | 6,459,973 | $7.8M | 12/31/2025 |
| Matrix Capital Management Company, LP | ▼ Sell | Open Market | 7,500,000 | $10.0M | 12/15/2025 |
| Luke Nathaniel Walker | ▲ Buy | Grant | 57,603 | $0 | 6/17/2025 |
| Jan Skvarka | ▲ Buy | Grant | 57,603 | $0 | 6/17/2025 |
| David Michael Johnson | ▲ Buy | Grant | 57,603 | $0 | 6/17/2025 |
| Enoch Kariuki | ▲ Buy | Grant | 57,603 | $0 | 6/17/2025 |
| Scott Dunseth Myers | ▲ Buy | Grant | 57,603 | $0 | 6/17/2025 |
| Scott Dunseth Myers | ▲ Buy | Open Market | 21,000 | $29K | 4/30/2025 |
| Ingmar Bruns | ▲ Buy | Open Market | 20,000 | $46K | 2/6/2025 |
| Mark Lackner | ▼ Sell | Open Market | 14,368 | $25K | 2/3/2025 |
| Andrea Paul | ▲ Buy | Grant | 934,041 | $0 | 2/3/2025 |
| Andrea Paul | ▼ Sell | Open Market | 13,230 | $23K | 2/3/2025 |
| Julia Marie Eastland | ▲ Buy | Grant | 59,388 | $0 | 2/3/2025 |
| Ingmar Bruns | ▲ Buy | Grant | 16,629 | $0 | 2/3/2025 |
| Vincent Vultaggio | ▲ Buy | Grant | 158,586 | $0 | 2/3/2025 |
| Vincent Vultaggio | ▼ Sell | Open Market | 2,615 | $4K | 2/3/2025 |
| Mark Lackner | ▲ Buy | Grant | 335,907 | $0 | 2/3/2025 |
| Jan Skvarka | ▲ Buy | Open Market | 60,000 | $103K | 1/31/2025 |
| Luke Nathaniel Walker | ▲ Buy | Open Market | 14,200 | $25K | 1/31/2025 |
| Julia Marie Eastland | ▲ Buy | Open Market | 28,500 | $49K | 1/31/2025 |
| Mark Lackner | ▼ Sell | Open Market | 4,411 | $14K | 1/2/2025 |
| Scott Dunseth Myers | ▲ Buy | Grant | 260,192 | $0 | 11/13/2024 |
| Vincent Vultaggio | ▼ Sell | Open Market | 1,603 | $5K | 10/4/2024 |
| Enoch Kariuki | ▲ Buy | Grant | 41,581 | $0 | 6/21/2024 |
| David Michael Johnson | ▲ Buy | Grant | 48,429 | $0 | 6/21/2024 |
| Jan Skvarka | ▲ Buy | Grant | 41,581 | $0 | 6/21/2024 |
| Cam Gallagher | ▼ Sell | Open Market | 9,597 | $115K | 5/31/2024 |
| Luke Nathaniel Walker | ▲ Buy | Grant | 72,481 | $0 | 5/24/2024 |
| Diana Hausman | ▼ Sell | Open Market | 3,356 | $42K | 5/9/2024 |
| Epperly Melissa B, | ▼ Sell | Open Market | 2,573 | $29K | 2/12/2024 |
| Cam Gallagher | ▼ Sell | Open Market | 1,173 | $13K | 2/12/2024 |
| Mark Lackner | ▼ Sell | Open Market | 1,585 | $18K | 2/2/2024 |
| Andrea Paul | ▼ Sell | Open Market | 3,310 | $38K | 2/2/2024 |
| Cam Gallagher | ▼ Sell | Open Market | 11,552 | $133K | 2/2/2024 |
| Epperly Melissa B, | ▼ Sell | Open Market | 8,669 | $100K | 2/2/2024 |
| Blackwell Kimberly | ▼ Sell | Tax Withholding | 20,655 | $241K | 2/1/2024 |
| Diana Hausman | ▲ Buy | Grant | 337,500 | $0 | 2/1/2024 |
| Epperly Melissa B, | ▲ Buy | Grant | 75,000 | $0 | 2/1/2024 |
| Blackwell Kimberly | ▲ Buy | Grant | 250,000 | $0 | 2/1/2024 |
| Mark Lackner | ▲ Buy | Grant | 141,000 | $0 | 2/1/2024 |
| Cam Gallagher | ▲ Buy | Grant | 192,500 | $0 | 2/1/2024 |
| Andrea Paul | ▲ Buy | Grant | 112,500 | $0 | 2/1/2024 |
| Mark Lackner | ▲ Buy | Grant | 40,000 | $0 | 1/2/2024 |
| Bunker Kevin D. | ▼ Sell | Gift | 24,158 | $0 | 12/20/2023 |
| Blackwell Kimberly | ▲ Buy | Open Market | 5,000 | $51K | 11/13/2023 |
| David Michael Johnson | ▲ Buy | Open Market | 17,000 | $168K | 11/10/2023 |
| Brownstein Carrie | ▼ Sell | Open Market | 8,906 | $173K | 10/4/2023 |
| Brownstein Carrie | ▼ Sell | Open Market | 1,722 | $34K | 10/4/2023 |
| Bunker Kevin D. | ▼ Sell | Open Market | 5,085 | $99K | 10/4/2023 |
| Bunker Kevin D. | ▼ Sell | Open Market | 983 | $20K | 10/4/2023 |
| Epperly Melissa B, | ▼ Sell | Open Market | 4,594 | $89K | 10/4/2023 |
| Epperly Melissa B, | ▼ Sell | Open Market | 888 | $18K | 10/4/2023 |
| Jan Skvarka | ▼ Sell | Open Market | 5,000 | $125K | 9/11/2023 |
| Matrix Capital Management Company, LP | ▲ Buy | Open Market | 4,760,000 | $107.9M | 6/20/2023 |
| David Michael Johnson | ▲ Buy | Grant | 19,059 | $0 | 6/16/2023 |
| Enoch Kariuki | ▲ Buy | Grant | 16,364 | $0 | 6/16/2023 |
| Jan Skvarka | ▲ Buy | Grant | 16,364 | $0 | 6/16/2023 |
| Cam Gallagher | ▼ Sell | Open Market | 9,242 | $244K | 5/31/2023 |
| Cam Gallagher | ▼ Sell | Open Market | 18,526 | $486K | 5/31/2023 |
| Bunker Kevin D. | ▼ Sell | Open Market | 80,000 | $2.4M | 5/26/2023 |
| Diana Hausman | ▲ Buy | Grant | 39,732 | $0 | 5/8/2023 |
| Roth Iris | ▲ Buy | Grant | 52,500 | $0 | 3/1/2023 |
| Cam Gallagher | ▼ Sell | Open Market | 8,501 | $170K | 2/14/2023 |
| Bunker Kevin D. | ▼ Sell | Open Market | 6,500 | $130K | 2/14/2023 |
| Epperly Melissa B, | ▼ Sell | Open Market | 5,227 | $104K | 2/14/2023 |
| Bunker Kevin D. | ▼ Sell | Open Market | 3,807 | $78K | 2/13/2023 |
| Cam Gallagher | ▼ Sell | Open Market | 3,332 | $68K | 2/13/2023 |
| Epperly Melissa B, | ▼ Sell | Open Market | 2,624 | $54K | 2/13/2023 |
| Cam Gallagher | ▼ Sell | Open Market | 9,428 | $210K | 2/6/2023 |
| Cam Gallagher | ▼ Sell | Open Market | 572 | $13K | 2/6/2023 |
| Andrea Paul | ▲ Buy | Grant | 40,783 | $0 | 2/1/2023 |
| Brownstein Carrie | ▲ Buy | Grant | 16,313 | $0 | 2/1/2023 |
| Epperly Melissa B, | ▲ Buy | Grant | 101,957 | $0 | 2/1/2023 |
| Cam Gallagher | ▲ Buy | Grant | 161,092 | $0 | 2/1/2023 |
| Bunker Kevin D. | ▲ Buy | Grant | 91,354 | $0 | 2/1/2023 |
| Blackwell Kimberly | ▲ Buy | Grant | 244,800 | $0 | 2/1/2023 |
| Cam Gallagher | ▼ Sell | Open Market | 9,500 | $229K | 1/17/2023 |
| Cam Gallagher | ▼ Sell | Open Market | 500 | $12K | 1/17/2023 |
| Cam Gallagher | ▼ Sell | Open Market | 9,700 | $204K | 1/5/2023 |
| Cam Gallagher | ▼ Sell | Open Market | 300 | $6K | 1/5/2023 |
| Cam Gallagher | ▼ Sell | Open Market | 11,600 | $264K | 11/15/2022 |
| Cam Gallagher | ▼ Sell | Open Market | 900 | $21K | 11/15/2022 |
| Bunker Kevin D. | ▼ Sell | Gift | 30,000 | $0 | 11/9/2022 |
| Cam Gallagher | ▼ Sell | Open Market | 12,374 | $292K | 11/8/2022 |
| Cam Gallagher | ▼ Sell | Open Market | 12,343 | $292K | 11/7/2022 |
| Cam Gallagher | ▼ Sell | Open Market | 157 | $4K | 11/7/2022 |
| Cam Gallagher | ▼ Sell | Open Market | 12,500 | $294K | 10/17/2022 |
| Cam Gallagher | ▼ Sell | Open Market | 10,000 | $226K | 10/6/2022 |
| Cam Gallagher | ▼ Sell | Open Market | 7,004 | $154K | 10/5/2022 |
| Cam Gallagher | ▼ Sell | Open Market | 5,496 | $125K | 10/5/2022 |
| Brownstein Carrie | ▲ Buy | Grant | 100,000 | $0 | 10/3/2022 |
| Bunker Kevin D. | ▲ Buy | Grant | 50,000 | $0 | 10/3/2022 |
| Epperly Melissa B, | ▲ Buy | Grant | 50,000 | $0 | 10/3/2022 |
| Cam Gallagher | ▼ Sell | Open Market | 8,866 | $216K | 9/16/2022 |
| Cam Gallagher | ▼ Sell | Open Market | 1,134 | $28K | 9/16/2022 |
| Cam Gallagher | ▼ Sell | Open Market | 8,426 | $212K | 9/15/2022 |
| Cam Gallagher | ▼ Sell | Open Market | 4,074 | $104K | 9/15/2022 |
| Jan Skvarka | ▲ Buy | Grant | 36,606 | $0 | 9/9/2022 |
| Bunker Kevin D. | ▼ Sell | Open Market | 5,000 | $150K | 8/10/2022 |
| Bunker Kevin D. | ▼ Sell | Open Market | 5,000 | $150K | 7/20/2022 |
| Bunker Kevin D. | ▼ Sell | Open Market | 3,290 | $99K | 7/14/2022 |
| Bunker Kevin D. | ▼ Sell | Open Market | 1,710 | $51K | 7/13/2022 |
| Bunker Kevin D. | ▼ Sell | Open Market | 25,000 | $752K | 7/5/2022 |
| Enoch Kariuki | ▲ Buy | Grant | 21,817 | $0 | 6/8/2022 |
| David Michael Johnson | ▲ Buy | Grant | 24,871 | $0 | 6/8/2022 |
| Cam Gallagher | ▲ Buy | Grant | 111,072 | $0 | 5/30/2022 |
| Bunker Kevin D. | ▼ Sell | Open Market | 4,600 | $140K | 4/11/2022 |
| Bunker Kevin D. | ▼ Sell | Open Market | 300 | $10K | 4/11/2022 |
| Bunker Kevin D. | ▼ Sell | Open Market | 100 | $3K | 4/11/2022 |
| SUN ANTHONY Y | ▼ Sell | Open Market | 7,971 | $409K | 4/5/2022 |
| SUN ANTHONY Y | ▼ Sell | Open Market | 2,500 | $130K | 4/5/2022 |
| Cam Gallagher | ▼ Sell | Open Market | 3,335 | $169K | 4/5/2022 |
| Cam Gallagher | ▼ Sell | Open Market | 2,196 | $113K | 4/5/2022 |
| Cam Gallagher | ▼ Sell | Open Market | 100 | $5K | 4/5/2022 |
| Cam Gallagher | ▼ Sell | Open Market | 4,369 | $217K | 4/5/2022 |
| Epperly Melissa B, | ▼ Sell | Open Market | 4,512 | $235K | 4/4/2022 |
| Epperly Melissa B, | ▼ Sell | Open Market | 353 | $19K | 4/4/2022 |
| SUN ANTHONY Y | ▼ Sell | Open Market | 10,471 | $508K | 4/4/2022 |
| Epperly Melissa B, | ▼ Sell | Open Market | 1,303 | $65K | 4/4/2022 |
| Epperly Melissa B, | ▼ Sell | Open Market | 2,818 | $143K | 4/4/2022 |
| Epperly Melissa B, | ▼ Sell | Open Market | 8,094 | $395K | 4/4/2022 |
| Bunker Kevin D. | ▼ Sell | Open Market | 4,444 | $220K | 3/21/2022 |
| Bunker Kevin D. | ▼ Sell | Open Market | 5,556 | $271K | 3/21/2022 |
| Cam Gallagher | ▼ Sell | Open Market | 4,578 | $190K | 3/15/2022 |
| Cam Gallagher | ▼ Sell | Open Market | 5,322 | $225K | 3/15/2022 |
| Cam Gallagher | ▼ Sell | Open Market | 100 | $4K | 3/15/2022 |
| Bunker Kevin D. | ▼ Sell | Open Market | 4,000 | $185K | 3/10/2022 |
| Bunker Kevin D. | ▼ Sell | Open Market | 4,301 | $203K | 3/10/2022 |
| Bunker Kevin D. | ▼ Sell | Open Market | 1,699 | $82K | 3/10/2022 |
| Cam Gallagher | ▼ Sell | Open Market | 9,477 | $426K | 3/7/2022 |
| Cam Gallagher | ▼ Sell | Open Market | 523 | $24K | 3/7/2022 |
| SUN ANTHONY Y | ▼ Sell | Open Market | 9,771 | $490K | 3/2/2022 |
| SUN ANTHONY Y | ▼ Sell | Open Market | 700 | $36K | 3/2/2022 |
| SUN ANTHONY Y | ▼ Sell | Open Market | 8,771 | $436K | 3/1/2022 |
| SUN ANTHONY Y | ▼ Sell | Open Market | 1,700 | $85K | 3/1/2022 |
| Epperly Melissa B, | ▼ Sell | Open Market | 1,211 | $59K | 2/23/2022 |
| Epperly Melissa B, | ▼ Sell | Open Market | 702 | $35K | 2/23/2022 |
| Bunker Kevin D. | ▼ Sell | Open Market | 2,451 | $122K | 2/22/2022 |
| Bunker Kevin D. | ▼ Sell | Open Market | 800 | $38K | 2/22/2022 |
| Bunker Kevin D. | ▼ Sell | Open Market | 6,343 | $310K | 2/22/2022 |
| Bunker Kevin D. | ▼ Sell | Open Market | 406 | $20K | 2/22/2022 |
| Cam Gallagher | ▼ Sell | Open Market | 3,264 | $167K | 2/15/2022 |
| Cam Gallagher | ▼ Sell | Open Market | 5,366 | $280K | 2/15/2022 |
| Cam Gallagher | ▼ Sell | Open Market | 1,370 | $72K | 2/15/2022 |
| Bunker Kevin D. | ▼ Sell | Open Market | 1,622 | $81K | 2/14/2022 |
| Bunker Kevin D. | ▼ Sell | Open Market | 203 | $10K | 2/14/2022 |
| Bunker Kevin D. | ▼ Sell | Open Market | 2,863 | $144K | 2/14/2022 |
| Voliotis Dimitris | ▼ Sell | Open Market | 534 | $27K | 2/14/2022 |
| Voliotis Dimitris | ▼ Sell | Open Market | 67 | $3K | 2/14/2022 |
| Pinto Alexis | ▼ Sell | Open Market | 77 | $4K | 2/14/2022 |
| Cam Gallagher | ▼ Sell | Open Market | 2,079 | $104K | 2/14/2022 |
| Cam Gallagher | ▼ Sell | Open Market | 259 | $13K | 2/14/2022 |
| Cam Gallagher | ▼ Sell | Open Market | 4,850 | $243K | 2/14/2022 |
| SUN ANTHONY Y | ▼ Sell | Open Market | 4,208 | $211K | 2/14/2022 |
| SUN ANTHONY Y | ▼ Sell | Open Market | 525 | $27K | 2/14/2022 |
| Pinto Alexis | ▼ Sell | Open Market | 614 | $31K | 2/14/2022 |
| Bunker Kevin D. | ▼ Sell | Open Market | 2,366 | $123K | 2/10/2022 |
| Bunker Kevin D. | ▼ Sell | Open Market | 3,074 | $164K | 2/10/2022 |
| Bunker Kevin D. | ▼ Sell | Open Market | 3,321 | $180K | 2/10/2022 |
| Bunker Kevin D. | ▼ Sell | Open Market | 1,239 | $68K | 2/10/2022 |
| Cam Gallagher | ▲ Buy | Grant | 7,595 | $0 | 2/10/2022 |
| SUN ANTHONY Y | ▲ Buy | Grant | 50,431 | $0 | 2/10/2022 |
| Epperly Melissa B, | ▲ Buy | Grant | 16,405 | $0 | 2/10/2022 |
| Pinto Alexis | ▲ Buy | Grant | 16,405 | $0 | 2/10/2022 |
| Cam Gallagher | ▲ Buy | Grant | 8,203 | $0 | 2/10/2022 |
| Voliotis Dimitris | ▲ Buy | Grant | 10,329 | $0 | 2/10/2022 |
| Bunker Kevin D. | ▲ Buy | Grant | 22,481 | $0 | 2/10/2022 |
| Cam Gallagher | ▼ Sell | Open Market | 2,290 | $121K | 2/7/2022 |
| Cam Gallagher | ▼ Sell | Open Market | 6,460 | $346K | 2/7/2022 |
| Cam Gallagher | ▼ Sell | Open Market | 1,250 | $68K | 2/7/2022 |
| SUN ANTHONY Y | ▼ Sell | Open Market | 8,128 | $470K | 2/2/2022 |
| SUN ANTHONY Y | ▼ Sell | Open Market | 2,343 | $137K | 2/2/2022 |
| SUN ANTHONY Y | ▼ Sell | Open Market | 4,124 | $234K | 2/1/2022 |
| SUN ANTHONY Y | ▼ Sell | Open Market | 3,419 | $197K | 2/1/2022 |
| SUN ANTHONY Y | ▼ Sell | Open Market | 2,828 | $166K | 2/1/2022 |
| SUN ANTHONY Y | ▼ Sell | Open Market | 100 | $6K | 2/1/2022 |
| Voliotis Dimitris | ▲ Buy | Option Exercise | 10,000 | $180K | 1/20/2022 |
| Voliotis Dimitris | ▼ Sell | Open Market | 8,343 | $505K | 1/20/2022 |
| Voliotis Dimitris | ▼ Sell | Open Market | 1,657 | $101K | 1/20/2022 |
| Bunker Kevin D. | ▼ Sell | Open Market | 2,753 | $163K | 1/20/2022 |
| Bunker Kevin D. | ▼ Sell | Open Market | 6,537 | $394K | 1/20/2022 |
| Bunker Kevin D. | ▼ Sell | Open Market | 710 | $44K | 1/20/2022 |
| Voliotis Dimitris | ▲ Buy | Option Exercise | 10,000 | $180K | 1/19/2022 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Leerink Partners initiates coverage of Zentalis at Outperform
Leerink Partners has begun covering Zentalis Pharmaceuticals with an Outperform rating and a price target of $8. This new analyst note places the target above the current average analyst estimate of $6.89. The move adds to the recent analyst activity surrounding the stock, which is currently trading near its 52-week range midpoint.
Leerink Partners initiates coverage of Zentalis at Outperform. Leerink Partners has begun covering Zentalis Pharmaceuticals with an Outperform rating and a price target of $8. This new analyst note places the target above the current average analyst estimate of $6.89. The move adds to the recent analyst activity surrounding the stock, which is currently trading near its 52-week range midpoint.